#prostate-cancer

Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy

Nakamura Ryuji, Kikuchi Koyo, Tanji Susumu, Yabuuchi Tomonori, Uwano Ikuko, Yamaguchi Satoshi, Ariga Hisanori, Fujioka, Fujioka Tomoaki

Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation

Zunich, Valdovinos Maria, Douglas Taneka, Walterhouse David, Iannaccone Philip, Lamm

Toxicity report of once weekly radiation therapy for low-risk prostate adenocarcinoma: preliminary results of a phase I/II trial

Menkarios Cathy, Vigneault Éric, Brochet Nicolas, Bahary Jean-Paul, Jolicoeur Marjory, Beauchemin Marie-Claude, Villeneuve Hugo, Van, Fortin Bernard, Lambert Carole, Nguyen

A network flow approach to predict drug targets from microarray data, disease genes and interactome network - case study on prostate cancer

Yeh Shih-Heng, Yeh Hsiang-Yuan, Soo, Soo Von-Wun

The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells

Brett Adina, Pandey Sony, Fraizer, Fraizer Gail

Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients

Chang Yu-Jun, Liang Wen-Miin, Wu Hsi-Chin, Lin Hsueh-Chun, Wang Jong-Yi, Li Tsai-Chung, Yeh Yi-Chun, Chang Chih-Hung, Chang

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer

Katz Alan, Ferrer Montserrat, Suárez José, Multicentric

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?

Strittmatter F, Stieber P, Nagel D, Füllhase C, Walther S, Stief Cg, Waidelich, Waidelich R

Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Mazeron Renaud, Bajard Agathe, Montbarbon Xavier, Gassa Frédéric, Malet Claude, Rocher François, Clippe Sébastien, Bringeon Gabriel, Desmettre Olivier, Pommier Pascal, Pommier

Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer

Hua Xing, Yu Lina, Pan Wenhai, Huang Xiaoxiao, Liao Zexiao, Xian Qi, Fang Li, Shen Hong, Shen

Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

Brooks Colin, Sheu Tommy, Bridges Kathleen, Mason Kathy, Kuban Deborah, Mathew Paul, Meyn, Meyn Raymond

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer

Røe Kathrine, Mikalsen, Bussink Johan, Lyng Heidi, Ree, Marignol Laure, Olsen, Van

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer

Pellacani Davide, Packer, Frame, Berry, Labarthe Marie-Christine, Stower, Simms, Maitland, Collins, Oldridge

Deprivation of arginine by recombinant human arginase in prostate cancer cells

Hsueh, Knebel, Lo Wai-Hung, Leung Yun-Chung, Cheng Paul, Hsueh Chung-Tsen

Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer

Vieira Samantha, Chinen, Chiappelli Francesco, Guimarães, Neves Ivan, Pagotty Simone, Pellionisz, Barkhordarian Andre, Brant Xenia, Ad, Soares, De, Rocha

Coffee consumption and prostate cancer risk: further evidence for inverse relationship

Mcloone Philip, Shafique Kashif, Qureshi Khaver, Leung Hing, Hart Carole, Morrison

Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer

Mak Daisy, Gill Suki, Paul Roxby, Stillie Alison, Haworth Annette, Kron Tomas, Cramb Jim, Knight Kellie, Thomas Jessica, Duchesne Gillian, Foroudi Farshad

Focal Laser Ablation of Prostate Cancer: Numerical Simulation of Temperature and Damage Distribution

Pierre Colin, Marqa Mohamad-Feras, Nevoux Pierre, Mordon, Betrouni, Betrouni Nacim

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups

Azelie Caroline, Gauthier Mélanie, Mirjolet Céline, Cormier Luc, Martin Etienne, Peignaux-Casasnovas Karine, Truc Gilles, Chamois Jérôme, Maingon Philippe, Créhange, Créhange Gilles

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost

Pinkawa Michael, Piroth, Holy Richard, Klotz Jens, Djukic Victoria, Caffaro Mariana, Winz, Krohn Thomas, Mottaghy, Eble, Escobar

Periostin: a promising target of therapeutical intervention for prostate cancer

Sun Chuanyu, Zhao Xiaojun, Gong Jian, Liu Weiwei, Ding Weihong, Gou Yuancheng, Xia Guowei, Ding, Ding Qiang, Ke Xu

Developing a nanoparticle test for prostate cancer scoring

Huo Qun, Litherland, Sullivan Shannon, Hallquist Hillari, Rivera-Ramirez, Rivera-Ramirez Inoel, Decker

Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens

Hong Heng, Mel Lin, Taylor Jonathan, Wu Qiang, Reeves, Reeves Hugh

Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study

Røe Kathrine, Kakar Manish, Seierstad Therese, Ree, Olsen

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy

Gill Suki, Thomas Jessica, Kron Tomas, Rolfo Aldo, Leahy Mary, Chander Sarat, Williams Scott, Duchesne, Foroudi Farshad, Tai, Fox Chris

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer

Murgic Jure, Stenmark, Halverson Schuyler, Blas Kevin, Hamstra, Feng

Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: A prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study

Herrmann, Kertesz Tereza, Gsänger Tammo, Bloch Eugen, Pollul Gerhard, Bouabdallaoui Mohamed, Strauss Arne, Herrmann Mareike, Christiansen Hans, Wolff, Hille Andrea, Hess

Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study

Kidd, Rogers, Beache Sydney, Rudd, Ragin Camille, Jackson Maria, Mcfarlane-Anderson Norma, Tulloch-Reid Marshall, Morrison Seian, Brock, Barve, Kimbro, Jones

Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells

Lee Tae-Jin, Sartor Oliver, Luftig, Koochekpour, Koochekpour Shahriar

Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning

Perna Lucia, Cozzarini Cesare, Maggiulli Eleonora, Fellin Gianni, Rancati Tiziana, Valdagni Riccardo, Vavassori Vittorio, Villa Sergio, Fiorino, Fiorino Claudio